Ipsen Group - Company & Market Research Reports

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

Somatostatin Analogs Market Size and Forecast by Type (Octreotide, Lanreotide, Pasireotide) by Indication (Acromegaly, Neuroendocrine Tumor (NET)) and Trend Analysis, 2014-2024 - Product Thumbnail Image

Somatostatin Analogs Market Size and Forecast by Type (Octreotide, Lanreotide, Pasireotide) by Indication (Acromegaly, Neuroendocrine Tumor (NET)) and Trend Analysis, 2014-2024

  • Report
  • 60 Pages
From
Acromegaly Treatment Market by Disease type , Diagnosis Type include Medical Imaging and Medical Laboratory Test and Treatment Type include Medication, surgery and Radiation Therapy: Global Forecast, 2016 - 2022 - Product Thumbnail Image

Acromegaly Treatment Market by Disease type , Diagnosis Type include Medical Imaging and Medical Laboratory Test and Treatment Type include Medication, surgery and Radiation Therapy: Global Forecast, 2016 - 2022

  • Report
  • 110 Pages
From
Post Menopausal Osteoporosis - Pipeline Review, H2 2018 - Product Thumbnail Image

Post Menopausal Osteoporosis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 92 Pages
From
Post Menopausal Osteoporosis - Pipeline Review, H1 2018 - Product Thumbnail Image

Post Menopausal Osteoporosis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 87 Pages
From
Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026 - Product Thumbnail Image

Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026

  • Report
  • 359 Pages
From
Post Menopausal Osteoporosis - Pipeline Insight, 2018 - Product Thumbnail Image

Post Menopausal Osteoporosis - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Attention Deficit Hyperactivity Disorder (ADHD): Market Intelligence Review and Insights - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD): Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Peptide Therapeutics in Metabolic Disorders, 2016 - 2025 - Product Thumbnail Image

Peptide Therapeutics in Metabolic Disorders, 2016 - 2025

  • Report
  • 436 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • 350 Pages
From
Osteoporosis - Pipeline Review, H1 2018 - Product Thumbnail Image

Osteoporosis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 251 Pages
From
Botulinum Toxin Market Analysis By Type (Botulinum Toxin Type A, Botulinum Toxin Type B), By End Use (Therapeutic, Aesthetic), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2013 - 2025 - Product Thumbnail Image

Botulinum Toxin Market Analysis By Type (Botulinum Toxin Type A, Botulinum Toxin Type B), By End Use (Therapeutic, Aesthetic), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2013 - 2025

  • Report
  • 90 Pages
From
Facial Injectible Market: By Type; By Application; By End Users & By Region - Forecast 2016-2022 - Product Thumbnail Image

Facial Injectible Market: By Type; By Application; By End Users & By Region - Forecast 2016-2022

  • Report
  • 151 Pages
From
Acromegaly Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Acromegaly Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 83 Pages
From
Pheochromocytoma - Pipeline Review, H2 2018 - Product Thumbnail Image

Pheochromocytoma - Pipeline Review, H2 2018

  • Drug Pipelines
  • 94 Pages
From
Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Pipeline Review, H2 2018 - Product Thumbnail Image

Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 64 Pages
From
Brain Hemorrhage - Pipeline Insight, 2018 - Product Thumbnail Image

Brain Hemorrhage - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Pheochromocytoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Pheochromocytoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 99 Pages
From
Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Pipeline Review, H1 2018 - Product Thumbnail Image

Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 66 Pages
From
Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 244 Pages
From
Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030

  • Report
  • 347 Pages
From
Loading Indicator
adroll